.
renchymal and pleural diseases, and mechanical com¬ plications of injection and inhalation. In 1988, we re¬ ported that nonopportunistic infections were most common in 51 intravenous (IV) drug users seen at our urban general hospital despite a high incidence of HIV antibody seropositivity.1 Since then, others have re¬ ported an increasing incidence of pneumocystis pneu¬ monia in drug users but a continuing high frequency of bacterial pneumonia and tuberculosis.2 The smok¬ ing of "crack" cocaine, which has increased dramati¬ cally in the past 10 The infectious pulmonary complications seen in our patients were primarily PCP, community-acquired pneumonia, and TB. PCP is the most common pul¬ monary infection seen in all patients with AIDS both IV and sexually acquired.8 In our patients, communi¬ ty-acquired pneumonia was common in both HIV-in¬ fected and noninfected IV drug users and uncommon in inhaled-only users. IV drug users have a 10-fold in¬ creased risk of community-acquiredpneumonia.9 HIVinfected drug users have a higher incidence of bacte¬ rial pneumonia than noninfected drug users and that risk increases as immunosuppression worsens. 5 
